Literature DB >> 20587087

Think (Gram) negative!

Benedikt Huttner1, Stephan Harbarth.   

Abstract

The increasing prevalence of multiresistant Gram-negative bacteria of the Enterobacteriaceae family in Europe is a worrisome phenomenon. Extended spectrum betalactamase-producing Escherichia coli strains are widespread in the community and are frequently imported into the hospital. Of even more concern is the spread of carbapenem-resistant strains of Klebsiella spp. from regions where they are already endemic. Antibiotic use is a main driver of antibiotic resistance, which again increases broad spectrum antibiotic use, resulting in a vicious circle that is difficult to interrupt. The present commentary highlights important findings of a surveillance study of antimicrobial use and resistance in German ICUs over 8 years with a focus on Gram-negative resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587087      PMCID: PMC2911742          DOI: 10.1186/cc9041

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  17 in total

1.  Multiresistance of gram-negative bacteria in intensive care units: bad news from without.

Authors:  S Harbarth; D Pittet
Journal:  Crit Care Med       Date:  1999-06       Impact factor: 7.598

2.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005.

Authors:  A Muller; S Coenen; D L Monnet; H Goossens
Journal:  Euro Surveill       Date:  2007-10-11

Review 3.  Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe.

Authors:  T M Coque; F Baquero; R Canton
Journal:  Euro Surveill       Date:  2008-11-20

4.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Authors:  Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

5.  Hospital antibiotic management in Germany--results of the ABS maturity survey of the ABS International group.

Authors:  Winfried V Kern; Michaela Steib-Bauert; Steffen Amann; Matthias Fellhauer; Katja de With
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 6.  MRSA burden and interventions.

Authors:  Lynne D Liebowitz
Journal:  Int J Antimicrob Agents       Date:  2009-08       Impact factor: 5.283

7.  Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.

Authors:  S Harbarth; A D Harris; Y Carmeli; M H Samore
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

Review 8.  Human health hazards from antimicrobial-resistant Escherichia coli of animal origin.

Authors:  Anette M Hammerum; Ole E Heuer
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

9.  High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients.

Authors:  Aránzazu Valverde; Fabio Grill; Teresa M Coque; Vicente Pintado; Fernando Baquero; Rafael Cantón; Javier Cobo
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

Review 10.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.